Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Cash flows from operating activities
Net loss	$ (5,736,603)	$ (6,803,716)
Adjustments to reconcile net loss to net cash used in operating activities
Depreciation and amortization	350,452	514,269
Non-cash interest expense	456,679	1,091,843
Stock compensation expense	211,122	241,619
Change in inventory reserve	256,814
Change in fair value of derivative liabilities	(12,694)	(109,744)
Changes in operating assets and liabilities
Accounts receivable	(142,177)	889,810
Inventory	(195,029)	(170,028)
Other assets	3,498	110,332
Accounts payable	(157,139)	(423,955)
Accrued compensation and other liabilities	100,388	(381,830)
Deferred revenue	(97,929)
Net cash used in operating activities	(4,962,618)	(5,041,400)
Cash flows from investing activities
Purchases of property and equipment	(330,446)	(38,713)
Net cash used in investing activities	(330,446)	(38,713)
Cash flows from financing activities
Proceeds from issuance of common stock and pre-funded warrants, net of issuance costs	6,974,050
Payments on debt	(2,229,560)
Payments on finance lease obligations	(841)	(17,529)
Net cash provided by (used in) financing activities	4,743,649	(17,529)
Effects of exchange rates on cash	150,186	(413,093)
Net decrease in cash and cash equivalents and restricted cash	(399,229)	(5,510,735)
Cash and cash equivalents and restricted cash at beginning of period	7,935,659	36,632,186
Cash and cash equivalents and restricted cash at end of period	7,536,430	31,121,451
Supplemental disclosure of cash flow information
Cash paid for interest	56,320	1,120
Supplemental disclosures of noncash investing and financing activities
Right-of-use assets acquired through operating leases	$ 801,321